Replies to post #798916 on NorthWest Biotherapeutics Inc (NWBO)

[dennisdave]

you disagree with todays PR ok

Flaskworks closed system as key to enabling DCVax-L production to begin taking place in Grade C suites rather than Grade B suites – and the Company views such transition to Grade C suites as central to large scale-up of production.